Medical/Pharmaceuticals
Seed Health Closes $40 Million in Series A Financing to Launch New Categories, Accelerate Global Distribution and Expand Clinical Research
LOS ANGELES, April 21, 2021 /PRNewswire/ -- Seed Health, a microbial sciences company developing next-generation probiotic applications and live biotherapeutics, today announced the close of a $40 million Series A financing led by impact investor,The Craftory, alongside TechBio investor ARTIS Ven...
2021-04-21 20:00
3122
Samsung Biologics Celebrates Its 10th Anniversary with Its Mission, "Driven. For Life."
INCHEON, South Korea, April 21, 2021 /PRNewswire/ -- Samsung Biologics, the
world's leading contract development and manufacturing organization, celebrated
the 10th anniversary of its founding today at its global headquarters in
Songdo, Incheon via a virtual ceremony.
2021-04-21 19:00
1970
#RosaceaUnmasked by Galderma unites the rosacea community to shine light on the impact of essential COVID-19 mask-wearing this Rosacea Awareness Month
- Rosacea sufferers join forces this Rosacea Awareness Month to bravely share the personal impact essential COVID-19 mask-wearing has on their skin condition - #RosaceaUnmasked encourages rosacea sufferers to speak with a doctor or dermatologist about the burden of regular mask-wearing on their r...
2021-04-21 17:29
2214
Mentice's CEO Göran Malmberg to present the company's interim report at a webcast conference call on April 28 at 9:30 CET
STOCKHOLM, April 21, 2021 /PRNewswire/ -- Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFOElisabet Lund. To register for the presentation of the...
2021-04-21 17:07
1253
GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme
SINGAPORE, April 21, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK)'s biopharmaceutical CDMO segment, GenScript ProBio announced a collaboration with the Experimental Drug Development Centre (EDDC),Singapore's national platform for drug discovery and development, on an a...
2021-04-21 11:08
5600
Ascentage Pharma to Announce Results from Four Clinical Studies at 2021 ASCO Annual Meeting, with Data of Its Drug Candidates Including Lisaftoclax (APG-2575) to Be Released in Oral Presentations for the First Time
SUZHOU, China and ROCKVILLE, Md., April 21, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that results from four clin...
2021-04-21 08:38
3097
Clinical Trial Industry Veteran Paul Malan Joins Bioforum as Vice President of Biostatistics
NESS ZIONA, Israel, April 21, 2021 /PRNewswire/ -- Bioforum
2021-04-21 06:00
2146
China Biologic Announces Completion of Going Private Transaction
BEIJING, April 20, 2021 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company inChina, today announced the completion of its merger (the "Merger") with CBPO Group Limited ("Merger...
2021-04-21 04:30
5772
Transcenta Received IND Clearance from US FDA for Initiating Phase I Clinical Trial for its Bi-functional Anti-PD-L1/TGF-β Antibody TST005
SUZHOU, China, April 20, 2021 /PRNewswire/ -- Transcenta Holding Limited (Transcenta), a clinical stage global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, today announced that it has received clearance of i...
2021-04-20 20:54
1303
Biovaxys And The World Ovarian Cancer Coalition Join Forces For May 8th, World Ovarian Cancer Day
VANCOUVER, BC and TORONTO, April 20, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys"), the world leader in haptenized antigen vaccines for antiviral and cancers applications, announced today its sponsorship of this year's World Ovarian Cancer Day, a ...
2021-04-20 20:00
4394
LimaCorporate Announces The First Surgery Of SMR Stemless Reverse Shoulder System In The IDE Study
SAN DANIELE DEL FRIULI, Italy, April 20, 2021 /PRNewswire/ -- LimaCorporate is proud to announce the first surgery performed in the SMR Stemless Reverse Shoulder System Investigational Device Exemption (IDE) study. This randomized, multi-center comparative clinical trial is currently evaluating t...
2021-04-20 20:00
2273
Mindray Unlocks Vast Patient Monitoring Potential with M-Connect Universally Connected Platform
SHENZHEN, China, April 20, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a leading global developer and provider of medical devices and integrated solutions, has launched its universally connected platform, M-Connect, which unlocks the potential of individual patient monitoring with an integrated ...
2021-04-20 15:00
5183
Holmusk continues ambitious US growth with NYC headquarters and expanded management team
NEW YORK, April 20, 2021 /PRNewswire/ -- Holmusk, a leading global data science and digital health company building the largest Real-World Evidence (RWE) platform for behavioral health, announced today the opening of its headquarters inNew York City and addition of three new members to its manage...
2021-04-20 14:00
2095
AACR 2021-ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration
SHENZHEN, China, April 19, 2021 /PRNewswire/ -- On April 15, 2021, ImmVira presents the preclinical study results of MVR-T3011 via intravenous administration through publication in a virtual poster at the AACR annual meeting. MVR-T3011 is a replication competent and genetically modified oncolyti...
2021-04-20 08:30
2022
iMDsoft announces Dedalus as their Channel Partner in Australia and New Zealand for MetaVision Clinical Information System, iMDsoft's best of class product suite
BRISBANE, Australia, April 20, 2021 /PRNewswire/ -- iMDsoft Ltd. and Dedalus are pleased to announce their Channel Partner Agreement, authorizing Dedalus to distribute MetaVision licenses and services, and support customers inAustralia andNew Zealand (ANZ). Through its Channel Partner program, i...
2021-04-20 07:01
2151
Abbott's Fast, Reliable and Convenient COVID-19 Tests Help the Philippines Fight Infection Surge
- Philippines scales its testing capability with two Abbott tests – a quick, patient-friendly rapid antigen test and lab-based quantitative antibody test - The Abbott Panbio™ COVID-19 Antigen Rapid Test Device comes with an easy-to-use nasal swab to detect active coronavirus infections in as earl...
2021-04-20 06:00
5267
Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform
LAKEWOOD, Colo. and BOCA RATON, Fla., April 19, 2021 /PRNewswire/ -- Terumo Blood and Cell Technologies and CSL Plasma today announce a collaboration to deliver a new plasma collection platform at CSL Plasma U.S. collection centers. A clinical trial of the investigational plasmapheresis device ...
2021-04-20 05:00
2601
Himalaya Therapeutics Announces Appointment of Nicholas Desjardins as Chief Financial Officer
SAN DIEGO, April 20, 2021 /PRNewswire/ -- Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, which are based ...
2021-04-20 01:42
2679
Sirtex Medical and BlackSwan Vascular, Inc. announce first patient enrolled in pivotal LAVA Study
LAVA clinical trial underway for potential first FDA-approved liquid embolic system for a peripheral vascular indication WOBURN, Mass., April 20, 2021 /PRNewswire/ -- Sirtex Medical (Sirtex), a leading manufacturer of targeted liver cancer therapies, and BlackSwan Vascular, Inc. (BlackSwan), a B...
2021-04-20 00:57
1639
ASG Superconductors with HZDR combine magnetic resonance imaging with proton therapy
Towards live imaging in cancer therapy GENOA, Italy, April 19, 2021 /PRNewswire/ -- ASG Superconductors with Helmholtz-Zentrum Dresden-Rossendorf (HZDR) will build the world's first prototype that tracks moving tumors with magnetic resonance imaging (MRI) in real time during proton therapy, comb...
2021-04-19 22:56
2817
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 262 media titles]
2025-12-29 09:00
ChinaAMC launches Depository Receipts of two Chinese flagship ETFs in Thai exchange
[Picked up by 259 media titles]
2025-12-29 14:27Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 255 media titles]
2025-12-30 20:12
